Medicare Enrolled

Dr. Alexander Perkelvald, MD

Endocrinology · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1720E 14TH ST M-2, Brooklyn, NY 11229
7183683333
In practice since 2006 (19 years)
NPI: 1679681639 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Perkelvald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perkelvald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Perkelvald

Dr. Alexander Perkelvald is an endocrinology specialist in Brooklyn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Perkelvald performed 2,275 Medicare services across 1,390 unique beneficiaries.

Between the years covered by Open Payments, Dr. Perkelvald received a total of $299,571 from 59 pharmaceutical and/or device companies across 1005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Perkelvald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in NY $299,571 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,275
Medicare services
Top 25% in NY for endocrinology
1,390
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~120 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,210 $112 $170
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
574 $105 $160
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
173 $147 $250
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
131 $30 $70
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $81 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
33 $13 $30
Ultrasound-guided fine needle aspiration biopsy, each additional growth
This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session.
27 $55 $200
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
22 $124 $200
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
21 $70 $110
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
20 $57 $80
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$299,571
Total received (2018-2024)
Avg $42,796/year across 7 years
Top 3% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,005
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$287,951 (96.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,620 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25,355
2023
$31,226
2022
$64,137
2021
$55,828
2020
$40,449
2019
$39,173
2018
$43,402

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$8,845
Novo Nordisk Inc
$7,019
ABBVIE INC.
$4,080
Intra-Sana Laboratories
$3,362
Corcept Therapeutics
$711
Lilly USA, LLC
$211
Novartis Pharmaceuticals Corporation
$197
Amneal Pharmaceuticals LLC
$154
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
IRONWOOD PHARMACEUTICALS, INC
$93
Kyowa Kirin, Inc.
$72
Insulet Corporation
$64
Xeris Pharmaceuticals, Inc.
$63
SANOFI-AVENTIS U.S. LLC
$50
AstraZeneca Pharmaceuticals LP
$47
Amgen Inc.
$41
CeQur Corporation
$40
Currax Pharmaceuticals LLC
$33
AIMMUNE THERAPEUTICS, INC.
$31
Chiesi USA, Inc.
$29
Ardelyx, Inc.
$28
TheracosBio, LLC
$24
Tandem Diabetes Care, Inc.
$15
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$156,223
Dexcom, Inc.
$48,709
AstraZeneca Pharmaceuticals LP
$35,981
Intuity Medical Inc
$10,753
AbbVie Inc.
$9,663
DEXCOM, INC.
$9,169
Kowa Pharmaceuticals America, Inc.
$6,420
ABBVIE INC.
$4,261
AbbVie, Inc.
$3,982
Intra-Sana Laboratories
$3,452
SANOFI-AVENTIS U.S. LLC
$1,301
Amgen Inc.
$917
Lilly USA, LLC
$784
Amneal Pharmaceuticals LLC
$782
Corcept Therapeutics
$711
Bayer HealthCare Pharmaceuticals Inc.
$699
Boehringer Ingelheim Pharmaceuticals, Inc.
$641
Novartis Pharmaceuticals Corporation
$605
Ironwood Pharmaceuticals, Inc
$336
Ipsen Biopharmaceuticals, Inc
$333
Xeris Pharmaceuticals, Inc.
$298
Insulet Corporation
$277
Amarin Pharma Inc.
$234
CeQur Corporation
$230
Horizon Therapeutics plc
$221
Shire North American Group Inc
$218
Allergan Inc.
$168
ARBOR PHARMACEUTICALS, INC.
$166
IRONWOOD PHARMACEUTICALS, INC
$163
Amryt Pharma Holdings Ltd
$160
Radius Health, Inc.
$159
Merck Sharp & Dohme Corporation
$131
Pharmacosmos Therapeutics Inc.
$125
Arbor Pharmaceuticals, Inc.
$124
Kyowa Kirin, Inc.
$118
Currax Pharmaceuticals LLC
$112
Regeneron Healthcare Solutions, Inc.
$93
NESTLE HEALTHCARE NUTRITION INC.
$91
Janssen Pharmaceuticals, Inc
$71
Abbott Laboratories
$69
Nestle HealthCare Nutrition Inc.
$61
VistaPharm, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
Zealand Pharma US, Inc.
$55
Tandem Diabetes Care, Inc.
$38
Gemini Laboratories, LLC
$38
Novo Nordisk AS
$31
AIMMUNE THERAPEUTICS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Chiesi USA, Inc.
$29
Ardelyx, Inc.
$28
TheracosBio, LLC
$24
VIVUS LLC
$22
Avanir Pharmaceuticals, Inc.
$22
Allergan, Inc.
$21
LifeScan, Inc.
$20
GlaxoSmithKline, LLC.
$20
Echosens North America, Inc.
$20
IBSA Pharma Inc.
$19
Top 3 companies account for 80.4% of all-time payments
Associated products mentioned in payments ›
ANORO · Aimovig · BAQSIMI · Brenzavvy · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FIASP · FibroScan · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYUMJEV · Linzess · Livalo · MOUNJARO · MYCAPSSA · Monoferric · NATPARA · NUEDEXTA · ONZETRA XSAIL · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pancreaze · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RELTONE 200 MG · RELTONE 400 MG · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SOMATULINE DEPOT · SPIRIVA RESPIMAT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULANCE · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · VIBERZI · Vascepa · Victoza · Wegovy · ZEGALOGUE · ZENPEP · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for endocrinology in NY.

Looking for an endocrinology specialist in Brooklyn?
Compare endocrinologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
635
Per 100K population
24.0
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Perkelvald is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Perkelvald experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Perkelvald performed 1,210 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perkelvald receive payments from pharmaceutical companies?
Yes. Dr. Perkelvald received a total of $299,571 from 59 companies across 1,005 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perkelvald's costs compare to other endocrinologists in Brooklyn?
Dr. Perkelvald's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perkelvald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →